Skip to main content
. 2007 Dec 26;2(12):e1348. doi: 10.1371/journal.pone.0001348

Figure 6. The predicted binding of TP5 and its alanine substitutions to HLA-DR.

Figure 6

The key residues (E11, N62) are in red; the other contacted residues are in orange. Peptide variants correspond to A: RKDVY; B: AKDVY; C: RADVY; D: RKAVY; E: RKDAY; F: RKDVA.